Nektar Therapeutics Stock (NASDAQ: NKTR) stock price, news, charts, stock research, profile.
Open | $1.37 |
Close | $1.38 |
Volume / Avg. | 912.29K / 1.94M |
Day Range | 1.31 - 1.41 |
52 Wk Range | 0.41 - 1.93 |
Market Cap | $253.95M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 6.76% |
Days to Cover | 5.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nektar Therapeutics (NASDAQ:NKTR) through any online brokerage.
Other companies in Nektar Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
There is no analysis for Nektar Therapeutics.
Nektar Therapeutics has a consensus price target of $7.56.
The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $1.38 last updated July 26, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Nektar Therapeutics.
Nektar Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Nektar Therapeutics.
Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.